Related by context. All words. (Click for frequent words.) 77 tumors 73 prostate cancers 71 prostate tumor 71 breast tumors 69 ovarian tumors 66 colon tumors 66 melanoma tumors 65 breast cancers 65 pancreatic tumors 65 colorectal tumors 65 tumor 65 cancerous tumors 65 lung tumors 64 pancreatic cancers 63 metastatic prostate cancer 63 cancers 62 tumor cells 62 mammary tumors 62 ovarian cancers 62 malignant tumors 62 prostate cancer 61 pre cancerous growths 61 cancerous cells 61 prostate tissue 61 pancreatic tumor 61 adenoma 61 pre cancerous lesions 60 Tumors 60 ovarian cancer 60 anaplastic 60 pre cancerous cells 60 endometrial cancers 60 colorectal cancer 59 cervical lesions 59 malignancy 59 grade gliomas 59 PCa 59 metastatic tumors 59 colorectal cancers 59 CLL cells 59 bowel cancers 59 precancerous lesions 59 glioblastoma 59 HER2 protein 58 atherosclerotic lesions 58 malignant cells 58 glioblastoma cells 58 lymphomas 58 HER2 positive breast cancer 58 DHFR 58 cyclin E 58 colon polyps 58 hedgehog pathway 58 noncancerous cells 58 glioblastomas 58 Tumours 58 pre cancerous polyps 58 lung cancers 58 cisplatin resistant 58 GBM tumors 57 isothiocyanates 57 sarcosine 57 bladder cancers 57 adenomas 57 colon cancers 57 breast lesions 57 melanomas 57 mammary cells 57 neuroblastoma cells 57 mutant protein 57 Glioblastoma multiforme GBM 57 seminoma 57 ptau 57 ovarian tumor 57 prostate cancer CaP 56 medulloblastoma 56 BCR ABL 56 breast carcinomas 56 tumor recurrence 56 bone metastasis 56 colorectal carcinoma 56 gliomas 56 aromatase 56 mesothelin 56 IGF 1R 56 melanoma 56 differentiated thyroid 56 gastric cancers 56 glioblastoma tumors 56 PGE2 56 aneuploid cells 56 mammary cancers 56 precancerous growths 56 precancerous 56 adenocarcinomas 56 neuroendocrine tumors 56 androgen receptor 56 B7 H3 56 metastatic cancer 56 endometrial tumors 56 DCIS 56 epithelial tumors 55 oncoprotein 55 inhibit tumor 55 prostate cancer PCa 55 prostate specific 55 Prostate tumors 55 transthyretin 55 metastatic lesions 55 leukaemic stem cells 55 ductal breast cancer 55 cancerdefine 55 BRAF gene 55 metastases 55 autoantibodies 55 colorectal cancer CRC 55 malignancies 55 GISTs 55 advanced adenomas 55 precancerous polyps 55 endostatin 55 HER2 positive 55 bladder tumors 55 MetAP2 55 ADPKD 55 myeloma cells 55 malignant growths 55 carcinoid cancer 55 metastatic melanomas 55 HNSCC 55 metastatic disease 55 prostate adenocarcinoma 55 colon cancer 55 endocrine tumors 55 esophageal adenocarcinoma 55 transgenic rats 55 BRAF mutation 55 HER2 overexpression 55 androgen receptors 55 EGFR protein 55 colorectal polyp 55 prostate gland 55 prostate 54 endometrial cancer 54 micrometastases 54 atherosclerotic plaques 54 benign polyps 54 xenograft tumors 54 MSMB 54 indolent tumors 54 Glioblastoma 54 specific antigen 54 Tumor cells 54 metastasis 54 precancerous cervical lesions 54 invasive breast cancer 54 solid tumors 54 malignant lymphoma 54 chitinase 54 cancerous growths 54 EGFR mutation 54 MUC1 * 54 benign growths 54 MIF protein 54 FGFR1 54 lymphoma 54 clusterin 54 serous ovarian cancer 54 breast cancer 54 benign proliferative breast 54 breast cancer metastasis 54 disease progression 54 glioma cells 54 leukaemias 54 neuroblastoma tumors 54 superficial bladder cancer 54 pancreatic cancer 54 fibrous tangles 54 BRAF protein 54 mutated protein 54 TAp# 54 intestinal polyps 54 malignant prostate 54 lung metastases 54 adenocarcinoma 54 mesothelial cells 54 amyloid deposits 54 precancers 54 breast cancer recurrence 54 premalignant 54 metastatic colon cancer 54 amyloid plaque 54 male hormones androgens 54 GIST tumors 53 brain tumors 53 WT1 53 ductal cancer 53 Akt1 53 SETDB1 53 tumor suppressor protein 53 suppresses tumor 53 indolent lymphoma 53 PKCi 53 seminomas 53 transgenic mice 53 mesenchymal cells 53 OGG1 53 epithelial ovarian cancer 53 EZH2 53 carcinoma 53 EphA2 53 c MYC 53 nestin 53 colon polyp 53 Epstein Barr virus EBV 53 HCV replication 53 EGFRvIII 53 PARP inhibitors 53 MMP9 53 M.tb 53 leukemic cells 53 NSCLC 53 mutant huntingtin 53 Polyps 53 breast epithelial cells 53 HGPIN 53 GSTP1 53 grade glioma 53 olaparib 53 acute myelogenous leukemia AML 53 Aβ 53 atypical hyperplasia 53 micronuclei 53 HPV# 53 hematopoietic cells 53 colorectal tumor 53 leukemic cell 53 antigen PSA 53 cancerous tissues 53 precancerous tumors 53 lobular carcinoma 53 colorectal neoplasms 53 genetic alteration 53 melanoma lesions 53 osteosarcomas 53 pancreatic adenocarcinoma 53 Cholangiocarcinoma 53 sulforaphane 53 bladder cancer 53 Crizotinib 53 prostate specific antigen 53 curable cancers 53 prostate cancer CRPC 53 IFNg 53 ErbB2 53 cancer 53 mutant proteins 53 colorectal gastric 53 chemopreventive 53 CD# protein 53 Carcinoid tumors 53 lung adenocarcinomas 53 PSADT 53 tumor regrowth 53 alveolar rhabdomyosarcoma 53 hormone estrogen 53 HER2 53 squamous cell lung cancer 53 amyloid proteins 53 HER2 positive cancers 53 HER2/neu 53 beta amyloid protein 53 gastric adenocarcinoma 53 precancerous cells 53 neuroblastomas 53 molecular abnormalities 53 Gleevec resistant 53 precancerous tissue 53 GRNOPC1 cells 53 carcinoid tumors 53 HER2 receptors 53 UCP2 53 MDM2 53 HER2 positive tumors 53 myoblasts 53 prostate glands 53 pituitary tumors 53 nonsmall cell lung cancer 52 uPAR 52 estrogen receptor negative 52 hormone deprivation 52 NSCLC tumors 52 Glioblastomas 52 castration resistant prostate cancer 52 inhibits tumor 52 myeloid cells 52 BRCA1 gene 52 inhibiting tumor 52 lung nodules 52 TB bacterium 52 neoplasia 52 HbF 52 Cancerous cells 52 mice genetically engineered 52 EGFR 52 PrPSc 52 thymosin 52 metastatic gastric 52 polyps growths 52 cancerous 52 urothelial cancer 52 narcolepsy cataplexy 52 metastatic melanoma 52 tumor progression 52 mesotheliomas 52 NKT cells 52 EGF receptor 52 estrogen receptors 52 Muc4 52 miRNA genes 52 colorectal polyps 52 lobular breast cancer 52 abnormal growths 52 GRK2 52 glioblastoma multiforme 52 fibrocytes 52 sporadic ALS 52 GSTT1 52 EGFr 52 squamous cell carcinomas 52 peritoneal carcinomatosis 52 premalignant lesions 52 CDK4 52 p# protein 52 Rectal cancer 52 prolongs survival 52 pituitary adenomas 52 follicular lymphoma 52 ovarian hormones 52 IDH2 52 myocytes 52 TGF beta pathway 52 precursor lesions 52 PKM2 52 beta1 integrin 52 liver metastases 52 squamous cell carcinoma SCC 52 acute promyelocytic leukemia 52 normal prion proteins 52 activin 52 cervical intraepithelial neoplasia 52 testicular cancers 52 CatB 52 LTB4 52 Cyclin D1 52 interferon beta 52 Stat5 52 malignant transformation 52 EGF receptors 52 SGK1 52 breast endometrial 52 hepatocellular carcinoma 52 pancreatic carcinoma 52 iNOS 52 overexpress 52 anticancer drugs 52 salinomycin 52 liposarcoma 52 osteoclast activity 52 androgen independent 52 miR #b [002] 52 factor receptor 52 mutated genes 52 TGF beta 52 EGFR mutations 52 basal cells 52 squamous cell cancer 52 BRCA deficient 52 gene amplification 52 glioma tumors 52 hCG beta 52 artery blockages 52 renal cell carcinomas 52 virally infected cells 52 prostate carcinoma 52 flavopiridol 52 basal cell carcinoma BCC 52 brain tumor glioblastoma multiforme 52 mutated KRAS gene 52 hTERT 52 interferon gamma 52 PCNSL 52 Barrett esophagus 52 recurrent glioblastoma multiforme GBM 52 BACE1 52 PI3K gene 52 nonseminoma 52 oral squamous cell 52 fungal meningitis 52 anti angiogenic drugs 52 glioma rarer 51 malignant pleural mesothelioma 51 malignant melanoma 51 polyps 51 aP2 51 elevated CRP 51 estrogen hormone 51 triptolide 51 3 carbinol 51 tumor suppressor genes 51 endometrial hyperplasia 51 incidentalomas 51 familial ALS 51 Mdm2 51 Acoustic neuromas 51 ALDH 51 IgG antibodies 51 leukemia AML 51 peptide antigens 51 mTOR inhibitors 51 Smac mimetic 51 ovarian carcinoma 51 transfected cells 51 carcinoid 51 vimentin 51 SOD1 51 tumor xenografts 51 CIN2 + 51 inhibit enzymes 51 inhibited tumor 51 synovial sarcoma 51 ACAT2 51 mammary cancer 51 nonmelanoma skin cancers 51 NKX2 51 pancreatic lung 51 huntingtin protein 51 primary cilia 51 castrate resistant 51 mutant SOD1 51 CaP 51 palladin 51 DFMO 51 androgen receptor AR 51 gastrointestinal stromal tumor 51 lung adenocarcinoma 51 acid secretion 51 CAG repeats 51 Glioblastoma multiforme 51 KRAS mutation 51 oesophageal adenocarcinoma 51 poorer prognosis 51 NFkB 51 BRCA mutation 51 Darapladib 51 GSK3 51 ependymoma 51 transplanted bone marrow 51 MDSCs 51 thyroid tumors 51 denser breasts 51 noncancerous tumors 51 leukaemic cells 51 PTEN protein 51 sulphoraphane 51 rhabdomyosarcoma 51 egg follicles 51 HER2 receptor 51 fibroadenomas 51 glioma 51 antisense inhibition 51 nonhormonal 51 atherosclerosis 51 genetic mutations 51 Srcasm 51 neoplastic cells 51 gamma tocopherol 51 hair follicle stem cells 51 detoxification enzymes 51 sortilin 51 pleural mesothelioma 51 urothelial carcinoma 51 prostate pancreatic 51 mutant p# 51 Malignant Melanoma 51 thyroid cancers 51 protein albumin 51 Glioma 51 PIK3CA 51 lung pancreatic 51 HER2 gene 51 Burkitt lymphoma 51 motor neuron degeneration 51 LRP5 51 angiogenesis inhibitor 51 FLT3 51 BMPR2 51 chemoresistance 51 precancer 51 oncogenes 51 malignant lesions 51 lymphoid tissue 51 caveolin 1 51 basal cell carcinomas 51 neural cells 51 glioblastoma tumor 51 renal carcinoma 51 type 1diabetes 51 KRAS gene 51 mutant BRAF 51 leukemias 51 renal cell carcinoma 51 anticancer agents 51 Skp2 51 lymphatic tissue 51 CCN2 51 TNFa 51 HER-2/neu 51 Zolinza 51 mitochondrial toxicity 51 SMN protein 51 MUC1 51 BRCA mutations 51 grade dysplasia 51 recurrent prostate cancer 51 STAT3 51 progranulin 51 GnRH agonists 51 distant metastasis 51 alpha carotene 51 astrocytoma 51 anaplastic lymphoma kinase 51 IGFBP 51 EBV infection 51 breast ovarian 51 Bcr Abl 51 hepatoma 51 BRAF mutations 51 nasopharyngeal carcinoma 51 KRAS oncogene 51 prostate cancer metastases 51 ABCA1 51 Glioblastoma Multiforme 51 ErbB2 positive 51 gastrointestinal stromal tumors 51 brain shrinkage 51 genistein 51 GBV C 51 p#NTR 51 hormone progesterone 51 breast tissue 51 SOD2 gene 51 faulty BRCA2 gene 51 beta islet cells 51 esophageal tumors 51 AAV2 51 cervical carcinoma 51 benign breast 51 prostate cancer AIPC 51 advanced adenoma 51 beta catenin protein 51 huntingtin gene 51 ApoE4 51 Peutz Jeghers syndrome 51 FGFR2 51 prostate walnut 51 RKIP 51 anaplastic lymphoma kinase ALK 51 BLyS 51 E#F# 51 gastric cancer 51 teratomas 51 lung metastasis 51 hepatocellular carcinoma HCC 51 angiosarcoma 51 metastatic renal cell carcinoma 51 RBP4 51 HER2 neu 51 acinar cells 51 colon carcinoma 51 interleukins 51 histone deacetylase inhibitors 51 HLA B# 51 somatostatin receptors 51 urease 51 stathmin gene 51 mutated KRAS 51 frequently benign tumor 51 Li Fraumeni 51 subependymal giant cell 50 bacterial enzymes 50 basal cell cancers 50 uveal melanoma 50 bowel polyps 50 medulloblastomas 50 DCIS lesions 50 polycystic ovary syndrome PCOS 50 anti Neu5Gc antibodies 50 Th# cells 50 mitochondrial fusion 50 miR #a [001] 50 lysozyme 50 Notch1 50 invasive ductal 50 LRP6 50 gene p# 50 tumor suppressor proteins 50 imatinib Gleevec 50 mtDNA mutations 50 Melanomas 50 invasive cervical cancer 50 medullary thyroid cancer 50 TGF β 50 CD# [002] 50 Testicular cancer 50 esophageal cancers 50 testicular germ cell 50 fatty plaques 50 chlamydial infection 50 NKX#.# 50 CCR3 50 Wwox 50 ZNF# 50 TH# cells 50 gastrointestinal stromal tumors GIST 50 TGF alpha 50 IDH1 mutations 50 NPY expression 50 SPINK1 50 liver cancer 50 MALT lymphoma 50 nanomolar 50 Hepatocellular Carcinoma HCC 50 polycystic ovarian syndrome PCOS 50 localized prostate cancer 50 Vpu 50 vulvar intraepithelial neoplasia 50 serum prostate 50 renal tumors 50 p# mutations 50 amyloid plaque formation 50 diagnose Alzheimer disease 50 4E BP1 50 IDH1 mutation 50 prostates 50 medulloblastoma tumors 50 liver metastasis 50 VZV 50 NF kB pathway 50 sarcomas 50 CGG repeats 50 Lrp5 50 precancerous cervical 50 pyruvate kinase 50 indolent NHL 50 neuroblastoma 50 ovarian lung 50 benign tumors 50 divide uncontrollably 50 xanthohumol 50 alpha synuclein 50 advanced neoplasia 50 utrophin 50 androgens 50 metastatic cancers 50 RIP1 50 parasite Leishmania 50 diabetic rats 50 T#I mutant 50 TGF beta signaling 50 BRCA1 mutations 50 hypermethylated 50 nutlin 3a 50 thyrotropin 50 CD8 cells 50 plasma kallikrein 50 luminal cells 50 urate 50 neuroendocrine cancers 50 cathepsins 50 GNAQ 50 cisplatin chemotherapy 50 isoflavones 50 trophoblast cells 50 cancerous nodules 50 E selectin 50 HCV infection 50 chronic lymphocytic leukemia CLL 50 intracellular pathways 50 telomere lengths 50 HDAC2 50 genetically modified mice 50 glandular tissue 50 breast carcinoma 50 amyloid beta peptides 50 cancerous tissue 50 IDH1 50 HDACs 50 TNF alpha 50 Th2 cytokines 50 tenascin C 50 cervical cancers 50 colorectal adenoma 50 lupus nephritis 50 SATB1 50 thyroid stimulating hormone 50 N Myc 50 SHBG levels 50 achromatopsia 50 neuroblastoma tumor 50 hormone secreting 50 urate levels 50 hormone ghrelin 50 mutations 50 Metastatic 50 abiraterone 50 Lodamin 50 metastatic 50 alkylating agents 50 limonoids 50 herpesviruses 50 cervical neoplasia 50 CXCR4 receptor 50 Gliomas 50 grade cervical intraepithelial 50 Basal cell 50 microRNA miR 50 radiolabeled antibodies 50 mitochondrial mutations 50 gastrointestinal stromal tumor GIST 50 chemotherapeutic agent 50 apigenin 50 antitumor effect 50 pre cancerous lesion 50 HER2 amplification 50 radiosensitivity 50 pre cancerous 50 infected macrophages 50 cruciferous vegetables 50 pDC 50 Bacterial infection 50 HPV infections 50 postoperative pathology 50 metastatic lung cancer 50 castrate resistant prostate cancer 50 enterovirus infection 50 β amyloid 50 IGF1 50 metastatic colorectal 50 castrated mice 50 Hedgehog pathway 50 Colon polyps 50 organophosphate exposure 50 VEGF receptor 50 commonly mutated genes 50 tumor antigen 50 collagenase 50 cPLA2 50 amino acid homocysteine 50 Malignant tumors 50 invasive lobular 50 GRP# 50 hormone refractory prostate cancer 50 tNOX 50 trophoblasts 50 invasive carcinoma 50 inoperable tumors 50 Scorpion venom 50 nanocell 50 Non Hodgkin lymphoma 50 microglial cells 50 HCMV 50 CCL# 50 spermidine 50 lymph node metastases 50 EGFR gene 50 transgene expression 50 metastatic prostate 50 disease NAFLD 50 sentinel nodes 50 choriocarcinoma 50 Htt 50 estrogen receptor 50 LY# [003] 50 trans retinoic acid 50 hamartomas 50 VEGF inhibitors 50 squamous cells 50 hormone LHRH 50 FGFR3 50 Aß 50 antioxidant enzyme 50 epithelial cancers 50 Dr. Bezprozvanny 50 nonalcoholic steatohepatitis NASH 50 NEDD9 50 DLBCL 50 PC3 cells 50 Ets2 50 precancerous colon polyps 50 germ cells 49 granzyme B 49 IgA antibodies 49 hypoxia inducible factor 49 Androgen deprivation therapy 49 KRAS mutations 49 bowel cancer 49 MAPCs 49 oxidized LDL 49 ependymomas 49 peritoneal cancer 49 calcitriol 49 interleukin IL -# 49 pancreas 49 estrogen receptor positive 49 oesophageal cancer 49 diseased cells 49 CD8 T cells 49 TRIM5a 49 leptin resistance 49 apoC III 49 osteopontin 49 hormone angiotensin II 49 specific antigen PSA 49 oncogene 49 esophageal squamous cell carcinoma 49 immunized mice 49 S#A# [002] 49 fenretinide 49 tumor metastases 49 genetic abnormalities 49 protein fragment 49 Wnt pathway 49 distant metastases 49 soluble receptor 49 CIN3 49 ductal carcinoma 49 CCR5 receptors 49 Helicobacter pylori H. pylori 49 MMP2 49 teratoma 49 PARP inhibitor 49 PIP3 49 molecularly targeted 49 recurrent glioblastoma 49 pancreatic islet 49 Rhabdomyosarcoma 49 endoglin 49 gene mutation 49 beta adrenergic receptors 49 telomerase inhibition 49 atypical ductal hyperplasia 49 vestibular schwannomas 49 myeloid leukemia 49 luteolin 49 CLL 49 Abeta# 49 PECAM 1 49 cysts 49 antibodies 49 elevated triglyceride levels 49 Mcl 1 49 Follicular lymphoma 49 G6PD 49 synthetic lethality 49 HER3 49 serum PSA 49 Aβ# 49 cystatin C 49 tumor subtypes 49 B Cell Lymphoma 49 naturally occurring molecule 49 genital herpes infections 49 tumor shrinkage 49 osteoblast 49 premenopausal breast cancer 49 mutant KRAS 49 non Hodgkin lymphoma 49 anti androgen 49 oligodendroglioma 49 amyloid fibrils 49 lysyl oxidase 49 PDE#A 49 androgen hormones 49 MAGE A3 49 activating mutations 49 MnSOD 49 precancerous spots 49 cancerous polyps 49 BRCA carriers 49 autoantibody 49 sporozoites 49 microRNAs 49 apoptotic cells 49 HDL particles 49 immunodeficient mice 49 neoplasias 49 ENaC 49 serotonin receptor 49 basal cell nevus syndrome 49 leukemia CLL 49 gastric carcinogenesis 49 PNET 49 germline stem cells 49 thyroglobulin 49 oncomodulin 49 invasive lobular carcinoma 49 microalbuminuria 49 endometrial carcinoma 49 carcinoma HNSCC 49 choroidal melanoma 49 neutralizing antibody 49 alpha defensins 49 lymphoma subtypes 49 prostate cancer mCRPC 49 lymphoid cells 49 liver fibrosis 49 gossypol 49 interferon pathway 49 MEFs 49 Pten gene 49 malaria parasite Plasmodium falciparum 49 antiproliferative effects 49 tau tangles 49 CMV infection 49 gastrointestinal cancers 49 CB2 receptors 49 premalignant lesion 49 cyclooxygenase 49 Glioblastoma Multiforme GBM 49 protein clumps 49 acute myeloid leukemia 49 prostrate cancer 49 PTEN mutations 49 uterine cancers 49 Smad7 49 TET2 49 chlamydial 49 EGFR inhibitors 49 MCF7 cells 49 thymidylate synthase 49 MMP inhibitors 49 Prostate Specific Antigen PSA 49 sarcoma 49 MYCN amplification 49 squamous cell cancers 49 untreated celiac disease 49 keloid 49 PLX# 49 synovial cells 49 CYP3A 49 prostaglandin E2 49 urothelial bladder cancer 49 immunocompromised mice 49 hyperplastic 49 Sjögren syndrome 49 transferrin receptors 49 lymphocytic leukemia 49 EGFR receptor 49 amyloid peptides 49 malignant ovarian 49 p# activation 49 neoplastic lesions 49 APOE e4 gene 49 pediatric malignancies 49 IGFBP 3 49 Clusterin 49 lymph nodes 49 phagocyte 49 castration resistant 49 pCR 49 Her-2/neu 49 mucinous 49 Carcinoma 49 T#I [002] 49 Alzheimer Disease AD 49 cultured cells 49 EGFR blockers 49 triterpenoids 49 ductal 49 phosphorylate 49 lactate dehydrogenase 49 NMP# protein 49 EGFR pathway 49 mutated BRCA1 49 cell carcinoma 49 female hormone estrogen 49 Cancers 49 endometrial cells 49 p#INK#a 49 gamma secretase inhibitor 49 preeclampsia 49 malignant polyps 49 micro RNA 49 TGF ß1 49 tumor suppressor 49 gastric carcinoma 49 JAK2 enzyme 49 AGTR1